Publication
Date | SPC No. | SPC
Category | Details
Rows may repeat to show multiple inventors or applicants depending on "Sort By" |
|---|
12 July 2017
(Journal 6686)
| SPC/GB05/030 | Expired | Applicant: Swedish Orphan Biovitrum International AB
SE-112 76 Stockholm, Sweden
Product: Nitisinone (2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione) or a pharmaceutically acceptable salt thereof
Product Type: Medicinal
Authorised: UK EU/1/04/303/001 21 February 2005
UK EU/1/04/303/002 21 February 2005
UK EU/1/04/303/003 21 February 2005
Authorised Extension:
Patent No: EP0591275
Title: Use of 2-(2-nitro-4-trifluoromethyl-benzoyl)-1, 3-cyclohexanedione in the treatment of tyrosinaemia and pharmaceutical compositions
SPC No: SPC/GB05/030
Date Expired: 17 June 2017 |
12 July 2017
(Journal 6686)
| SPC/GB07/062 | Expired | Applicant: Bristol-Myers Squibb Company
345 Park Avenue, New York, NY 10154, United States of America
Product: abatacept
Product Type: Medicinal
Authorised: UK EU/1/07/389/001 21 May 2007
UK EU/1/07/389/002 21 May 2007
UK EU/1/07/389/003 21 May 2007
Authorised Extension: EU/1/07/389/001-003 20 January 2010
Patent No: EP0606217
Title: CTL4A receptor, fusion proteins containing it and uses thereof
SPC No: SPC/GB07/062
Date Expired: 15 June 2017 |
12 July 2017
(Journal 6686)
| SPC/GB17/037 | Lodged | Applicant: Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road, Tarrytown, New York 10591, USA
Product: alirocumab
Product Type: Medicinal
Authorised: UK EU/1/15/1031 23 September 2015
Authorised Extension:
Patent No: EP2358756
Title: High affinity human antibodies to PCSK9
SPC No: SPC/GB17/037
Date Lodged: 16 June 2017 |
12 July 2017
(Journal 6686)
| | Expired | Bristol-Myers Squibb Company
345 Park Avenue, New York, NY 10154, United States of America
Product: abatacept
Product Type: Medicinal
Authorised: UK EU/1/07/389/001 - 21 May 2007
UK EU/1/07/389/002 - 21 May 2007
UK EU/1/07/389/003 - 21 May 2007
Authorised Extension: EU/1/07/389/001-003 - 20
January 2010
Patent No: EP0606217
Title: CTL4A receptor, fusion proteins containing it and uses thereof
SPC Number: SPC/GB07/062
Date Expired: 15 June 2017
A Paediatric Extension was granted on the above application SPC/GB07/0623 on 6 January 2011 (Journal 6349 - 26.01.2011) with an expiry date of 15 December 2017. |
